Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Martin Tue Mikkelsen"'
Autor:
Mette Simone Aae Madsen, Niels Vrang, Kristoffer T.G. Rigbolt, Martin Tue Mikkelsen, Rikke Veggerby Grønlund, Henrik H. Hansen, John Eid, Martin R. Madsen, Jacob Jelsing, Mikkel Christensen-Dalsgaard, Morten Otto Alexander Sommer
Publikováno v:
Madsen, M S A, Grønlund, R V, Eid, J, Christensen-Dalsgaard, M, Sommer, M O A, Rigbolt, K, Madsen, M R, Jelsing, J, Vrang, N, Hansen, H H & Mikkelsen, M T 2021, ' Characterization of local gut microbiome and intestinal transcriptome responses to rosiglitazone treatment in diabetic db/db mice ', Biomedicine and Pharmacotherapy, vol. 133, 110966 . https://doi.org/10.1016/j.biopha.2020.110966
Biomedicine & Pharmacotherapy, Vol 133, Iss, Pp 110966-(2021)
Biomedicine & Pharmacotherapy, Vol 133, Iss, Pp 110966-(2021)
The gut microbiota has been implicated in the therapeutic effects of antidiabetics. It is unclear if antidiabetics directly influences gut microbiome-host interaction. Oral peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists, such as ros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85f2e00c6d1ca24a3497296877eebe2d
https://orbit.dtu.dk/en/publications/c7ed2afc-ed03-48cc-bf2f-189dd40a0a6b
https://orbit.dtu.dk/en/publications/c7ed2afc-ed03-48cc-bf2f-189dd40a0a6b
Autor:
Mette Simone Aae Madsen, Jacob Bak Holm, Morten Otto Alexander Sommer, Jacob Jelsing, Niels Vrang, Katrine Fabricius, Henrik H. Hansen, Kristoffer T. G. Rigbolt, Pernille Wismann, Albert Pallejà, Martin Tue Mikkelsen, Henrik Nielsen
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
Scientific Reports
Madsen, M S A, Holm, J B, Pallejà, A, Wismann, P, Fabricius, K, Rigbolt, K, Mikkelsen, M T, Sommer, M O A, Jelsing, J, Nielsen, H B, Vrang, N & Hansen, H H 2019, ' Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice ', Scientific Reports, vol. 9, 15582 . https://doi.org/10.1038/s41598-019-52103-x
Scientific Reports
Madsen, M S A, Holm, J B, Pallejà, A, Wismann, P, Fabricius, K, Rigbolt, K, Mikkelsen, M T, Sommer, M O A, Jelsing, J, Nielsen, H B, Vrang, N & Hansen, H H 2019, ' Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice ', Scientific Reports, vol. 9, 15582 . https://doi.org/10.1038/s41598-019-52103-x
Enteroendocrine L-cell derived peptide hormones, notably glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2), have become important targets in the treatment of type 2 diabetes, obesity and intestinal diseases. As gut microbial imbalan